Location History:
- Palo Alto, CA (US) (2008)
- Austin, TX (US) (2014 - 2020)
Company Filing History:
8 out of 5,448 
3 out of 37 Years Active: 2008-2020
Title: The Innovative Contributions of Jennifer A. Maynard in Antibody Development
Introduction: Jennifer A. Maynard, based in Palo Alto, CA, is a prominent inventor known for her significant contributions to the field of biotechnology, particularly in the development of bispecific and humanized antibodies. With a portfolio that includes eight patents, she has been at the forefront of innovations aimed at combating infectious diseases through novel antibody therapies.
Latest Patents: Maynard's latest patented inventions include bispecific pertussis antibodies, which are designed to bind specifically to the pertussis toxin protein. These antibodies are not only revolutionary but also promise efficacy in the prevention and treatment of infections caused by this pathogen. Additionally, her work on humanized pertussis antibodies focuses on the development of improved therapeutic agents. Specifically, her innovations with the 1B7 and 11E6 humanized antibodies have shown great potential in binding to the toxin protein, enhancing the therapeutic effects.
Career Highlights: Throughout her career, Jennifer has held esteemed positions at the University of Texas System and Synthetic Biologics, Inc. Her roles have facilitated groundbreaking research and the practical application of her inventions in the medical field.
Collaborations: Maynard’s work has often involved collaboration with distinguished colleagues, including Ellen Wagner and Annalee Nguyen. These partnerships have not only enriched her research but have also led to diverse insights and advancements in antibody development.
Conclusion: Jennifer A. Maynard's innovative work continues to impact the field of biomedicine significantly. Her expertise in antibody technology is paving the way for new therapeutic solutions, showcasing her role as a leading inventor in addressing critical health challenges. Her contributions are a testament to the power of innovation in enhancing human health.